YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Self-verification and Support Via Mobile Phones Drastically Improves Tuberculosis Treatment Success in LMIC Settings

Not Applicable

Completed

Conditions: Tuberculosis

Interventions: Behavioral: Keheala
Other: Standard of Care

First Posted Date: 2017-05-01

Last Posted Date: 2019-07-23

Lead Sponsor: Yale University

Target Recruit Count: 1190

Registration Number: NCT03135366

The Effect of Nicotine Delivery Rate on Reinforcement

Early Phase 1

Completed

Conditions: Nicotine

Interventions: Drug: Nicotine 0.048 mcg/kg/s
Drug: Nicotine 0.024 mcg/kg/s
Drug: Nicotine saline 0.00mcg/kg/s
Drug: Nicotine 0.24 mcg/kg/s

First Posted Date: 2017-04-28

Last Posted Date: 2018-10-22

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT03134339

Locations: 🇺🇸
VA Hospital, West Haven, Connecticut, United States

Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia

Phase 2

Terminated

Conditions: Obesity
Diabetes Mellitus, Type 2
Schizophrenia

Interventions: Drug: Naltrexone
Drug: Bupropion
Other: Placebo

First Posted Date: 2017-04-28

Last Posted Date: 2019-08-07

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT03132571

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection

Not Applicable

Completed

Conditions: Skin Neoplasms

Interventions: Behavioral: Standard of care control
Behavioral: Indoor tanning intervention

First Posted Date: 2017-04-27

Last Posted Date: 2018-06-26

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT03132012

Locations: 🇺🇸
Yale School of Public Health, New Haven, Connecticut, United States

Creating Naptime: An Overnight, Non-Pharmacologic Intensive Care Unit Sleep Promotion Protocol

Not Applicable

Completed

Conditions: Sleep

Interventions: Behavioral: Naptime Protocol

First Posted Date: 2017-04-18

Last Posted Date: 2017-04-18

Lead Sponsor: Yale University

Target Recruit Count: 85

Registration Number: NCT03119207

Toradol to Reduce Ureteroscopic Symptoms Trial

Phase 2

Completed

Conditions: Urinary Lithiasis
Kidney Stone
Kidney Diseases
Pain, Postoperative

Interventions: Drug: Toradol

First Posted Date: 2017-04-12

Last Posted Date: 2021-11-02

Lead Sponsor: Yale University

Target Recruit Count: 94

Registration Number: NCT03111381

Locations: 🇺🇸
Yale Medial Center, New Haven, Connecticut, United States

Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: smokeSCREEN game

First Posted Date: 2017-04-11

Last Posted Date: 2018-10-19

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT03107936

Locations: 🇺🇸
Hamden Youth Center, Hamden, Connecticut, United States
🇺🇸
Leadership, Education, and Athletics Partnership (LEAP) Inc., New Haven, Connecticut, United States
🇺🇸
Farnam Neighborhood House, New Haven, Connecticut, United States

and more 1 locations

The Neural Correlates of Cannabis Use

Completed

Conditions: Cannabis Dependence
Healthy

Interventions: Drug: [11-C]OMAR

First Posted Date: 2017-04-07

Last Posted Date: 2024-03-12

Lead Sponsor: Yale University

Target Recruit Count: 162

Registration Number: NCT03104257

Locations: 🇺🇸
Conneticut Mental Health Center, New Haven, Connecticut, United States

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

Phase 1

Completed

Conditions: ADHD

Interventions: Procedure: Magnetic Resonance Imaging (MRI)
Drug: PHNO
Dietary Supplement: calcitriol
Drug: Placebo oral capsule
Procedure: high-resolution research tomography
Drug: Dextro Amphetamine

First Posted Date: 2017-04-06

Last Posted Date: 2024-03-19

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT03103750

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: neoadjuvant mFOLFIRINOX
Drug: Stereotactic body radiotherapy (SBRT)

First Posted Date: 2017-04-04

Last Posted Date: 2022-10-27

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT03099265

Locations: 🇺🇸
Smilow Cancer Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy